Absci Corporation (ABSI)
9.07
+0.53 (6.21%)
Upcoming Events
Latest Headlines
H.C. Wainwright Reiterates Buy Rating on Absci Corp. (ABSI)
October 20, 2026 6:50 AM - StreetInsider
Absci Corp. (ABSI) PT Raised to $20 at KeyBanc
October 16, 2026 9:11 AM - StreetInsider
Form 4 Absci Corp For: Oct 12 Filed by: McClain Sean
October 14, 2026 7:16 PM - SEC Filing
Form 4 Absci Corp For: Oct 12 Filed by: Bedrick Todd
October 14, 2026 7:16 PM - SEC Filing
Form 4 Absci Corp For: Oct 12 Filed by: Jonasson Zachariah
October 14, 2026 7:15 PM - SEC Filing
AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test
October 14, 2026 9:45 AM - StreetInsider
Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026
October 13, 2026 8:00 AM - StreetInsider
Guggenheim Reiterates Buy Rating on Absci Corp. (ABSI)
September 28, 2026 1:33 AM - StreetInsider
Absci plans Phase 2 trial of ABS-201 for endometriosis in mid-2027
September 24, 2026 8:00 AM - StreetInsider
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
September 24, 2026 8:00 AM - Globe NewsWire
Absci to Participate in Upcoming Investor Conferences
September 1, 2026 8:00 AM - StreetInsider
Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
August 19, 2026 8:56 AM - StreetInsider
Absci Corporation (ABSI) Misses Q2 EPS by 2c
August 11, 2026 4:24 PM - StreetInsider
Form 10-Q Absci Corp For: Jun 30
August 11, 2026 4:09 PM - SEC Filing
Form 8-K Absci Corp For: Aug 11
August 11, 2026 4:07 PM - SEC Filing
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
August 11, 2026 4:05 PM - StreetInsider
Form 4 Absci Corp For: Mar 03 Filed by: Somaratne Ransi Mudalinayake
August 7, 2026 4:54 PM - SEC Filing
Form 3 Absci Corp For: Mar 03 Filed by: Somaratne Ransi Mudalinayake
August 7, 2026 4:54 PM - SEC Filing
Full Article List
